Format

Send to

Choose Destination
See comment in PubMed Commons below
Annu Rev Med. 2006;57:313-29.

Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia.

Author information

  • 1Department of Medicine, Division of Digestive Diseases, Howard Hughes Medical Institute, University of California, Los Angeles, California 90095-1662, USA. sbeaven@mednet.ucla.edu

Abstract

Dyslipidemia is the sine qua non of atherosclerosis, but it is also strongly associated with the metabolic syndrome, obesity, diabetes, and fatty liver disease. The molecular basis for future therapies requires understanding the pivotal role of nuclear hormone receptors in lipid and inflammatory homeostasis. This review summarizes evidence that the liver X receptor (LXR) and peroxisome proliferator-activated receptor (PPAR) are key transcriptional regulators in lipid metabolism. Additionally, their effects on glucose homeostasis and inflammation make LXR and PPAR signaling networks attractive molecular targets for managing lipid-related diseases.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center